IPO Trending
SENORESEQ / NSE, BSEListed

Senores Pharmaceuticals Limited

Senores Pharmaceuticals Limited, incorporated on December 26, 2017, is an Ahmedabad-based pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic medicines for both domestic and global markets. Its diversified product portfolio spans key therapeutic areas, including gastrointestinal, cardiovascular, respiratory, pain management, and anti-infective segments. Driven by strong R&D capabilities, the company emphasizes innovation, cost-effective product development, and strict regulatory compliance. Senores operates through a robust distribution network supported by subsidiaries such as Ratnatris Pharmaceuticals Private Limited and Havix Group, Inc. (Aavis Pharmaceuticals). It serves customers across major international markets, including the US, Europe, and other emerging regions.

₹372 - ₹39197.25x sub
Listed Price600.00
Listing Gain+53.45%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Period Ended )0 Cr
Growth-100.0%
Revenue Trend (₹ in Crores)
0.083.2166.4249.5Mar-22Mar-23 Mar-24 Sep-24 Period Ended
PeriodRev (Cr)PAT (Cr)AssetsDebt
Period Ended RevenueProfit After Tax AssetsTotal Borrowing
Sep-24 18324678242
Mar-24 21733 622248
Mar-23 39813161
Mar-221515914
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Sep-24 7.208.69%7.59%028.21
Mar-24 13.6723.60%11.73%39.770
Mar-238.8720.55%18.56%00